77 Se Hyperpolarization Enabled by Reversible Parahydrogen Exchange and Audio-Frequency Magnetic Fields at 0.1 mT
Source abstract
Abstract
Nuclear spin hyperpolarization boosts NMR sensitivity but typically requires complex infrastructure. Signal Amplification by Reversible Exchange (SABRE), a parahydrogen-based hyperpolarization technique, can be conducted using a remarkably low-cost polarizer (<$100) comprising only magnetic coils and a standard PC sound card, avoiding magnetic shielding. However, under these conditions, SABRE requires direct spin-coupling between parahydrogen and the target nucleus, limiting its application to distant heteronuclear spins such as 77 Se in biologically relevant selenium–nitrogen heterocycles (e.g., antioxidant, antiviral, and anticancer agents). Here, we overcome the distance restrictions by developing 15 N-mediated polarization transfer driven by oscillating magnetic fields of the audio frequency. As a proof-of-concept, we achieve a 11600-fold enhancement of the 77 Se NMR signal (>6% net polarization) at 9.4 T in a shielding-free setup using a selenadiazole derivative. These results suggest that selenadiazole-based compounds are particularly well suited for this strategy and provide a basis for extending it to other selenium-containing molecules.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced NMR Techniques and Applications · Atomic and Subatomic Physics Research · Quantum, superfluid, helium dynamics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
International Tomography Center, Siberian Branch of the Russian Academy of Science, Institutskaya 3A, Novosibirsk 630090, Russia
R.E. Alekseev Nizhny Novgorod State Technical University
Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Science, Vavilova 28/1, Moscow 119334, Russia
Funding
Russian Science Foundation · Ministry of Science and Higher Education of the Russian Federation
References (40)
Show source-provided references
1. 10.1126/science.116887710.1126/science.1168877 ↗
2. 10.1002/anie.20171040610.1002/anie.201710406 ↗
3. 10.1039/D2RA01346K10.1039/D2RA01346K ↗
4. 10.1021/acs.chemrev.2c0053410.1021/acs.chemrev.2c00534 ↗
5. 10.1021/ja512242d10.1021/ja512242d ↗
6. 10.1002/anie.20190548310.1002/anie.201905483 ↗
7. 10.7150/thno.10327210.7150/thno.103272 ↗
8. 10.1002/ange.20250123110.1002/ange.202501231 ↗
9. 10.1002/cptc.20230015110.1002/cptc.202300151 ↗
10. 10.7150/thno.10327210.7150/thno.103272 ↗
11. 10.1002/open.20170016610.1002/open.201700166 ↗
12. 10.1039/C6CC07109K10.1039/C6CC07109K ↗
13. 10.1021/acs.jpcb.5b0068610.1021/acs.jpcb.5b00686 ↗
14. 10.1021/jacs.5c0645010.1021/jacs.5c06450 ↗
15. 10.3390/antiox705006610.3390/antiox7050066 ↗
16. 10.3390/ijms2203100910.3390/ijms22031009 ↗
17. 10.3390/futurepharmacol204003610.3390/futurepharmacol2040036 ↗
18. 10.1002/anie.20170481610.1002/anie.201704816 ↗
19. 10.1021/jacs.0c0855710.1021/jacs.0c08557 ↗
20. 10.1021/acs.jpcc.5b0179910.1021/acs.jpcc.5b01799 ↗
21. 10.1021/jacs.6b0478410.1021/jacs.6b04784 ↗
22. 10.1063/5.023684110.1063/5.0236841 ↗
23. 10.1039/D1CP03164C10.1039/D1CP03164C ↗
24. 10.1039/C7CP08529J10.1039/C7CP08529J ↗
25. 10.1002/cmtd.20240006010.1002/cmtd.202400060 ↗
26. 10.1016/j.jmr.2016.01.01510.1016/j.jmr.2016.01.015 ↗
27. 10.1021/acs.jmedchem.1c0185910.1021/acs.jmedchem.1c01859 ↗
28. 10.1016/j.ejmech.2021.11362110.1016/j.ejmech.2021.113621 ↗
29. 10.1021/acs.jmedchem.9b0115210.1021/acs.jmedchem.9b01152 ↗
30. 10.1016/j.ejmech.2018.07.06310.1016/j.ejmech.2018.07.063 ↗
31. 10.1002/ardp.20100001410.1002/ardp.201000014 ↗
32. 10.1039/C5TB01501D10.1039/C5TB01501D ↗
33. 10.1021/acs.bioconjchem.8b0024710.1021/acs.bioconjchem.8b00247 ↗
34. 10.1080/00268976.2018.151599910.1080/00268976.2018.1515999 ↗
35. 10.1016/j.jmr.2014.09.00510.1016/j.jmr.2014.09.005 ↗
36. 10.1021/acs.jpcc.3c0112810.1021/acs.jpcc.3c01128 ↗
37. 10.1016/j.pnmrs.2014.06.00110.1016/j.pnmrs.2014.06.001 ↗
38. 10.1002/cphc.20130059510.1002/cphc.201300595 ↗
39. Levitt M. H. · 2008
40. 10.1021/acs.jpcc.7b1148510.1021/acs.jpcc.7b11485 ↗